Want to join the conversation?
$LII narrowed its guidance for 2016 revenue growth from 3-7% to 4-6%, and still expects ForEx to be neutral to revenue on a full-year basis. The company updated its guidance for 2016 GAAP EPS from continuing operations from $6.45-6.85 to a range of $6.25-6.45, and adjusted EPS from continuing operations from $6.50-6.90 to a range of $6.75-6.95.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.